AbbVie Inc. (ABBV) Stock Analysis
By stockpickr AI | March 1, 2026 | 10 min read
Investment Summary
AbbVie is a solid healthcare company with a sustainable dividend and strong product pipeline, making it a compelling buy for long-term investors.
Investment Recommendation
Buy
Fair Value: $215.50
Current Price: $173.05
Upside/Downside: +24.5%
The DCF analysis suggests AbbVie's intrinsic value per share is significantly higher than its current market price, driven by strong projected free cash flow and a reasonable terminal growth rate.
Key Metrics
- No metrics available